Literature DB >> 12601476

[Sporadic adenoma and colitis-associated intraepithelial neoplasia: a difficult differential diagnosis].

M Vieth1, H Behrens, M Stolte.   

Abstract

The differential diagnosis between sporadic adenoma and colitis-associated neoplasia is difficult. Clinical, histological and molecular genetic methods are available to recognise a difference between these two entities. The aim of the present analysis was to check known criteria in a large series of patients and 352 patients with ulcerative colitis and concomitant intraepithelial neoplastic lesions [149 adenomas (A), 123 colitis-associated intraepithelial neoplasias (N), 80 carcinomas (K)] were investigated. Clinical history helped to identify patients with sporadic adenoma since patients with colitis-associated neoplastic lesions presented with different data such as age (A: 61.3+/-13 years, N: 48.4+/-16.4 years, K: 53.9+/-16.9 years), duration of disease (A: 6.9+/-8.1 years, N: 11.9+/-10 years, K: 13.6+/-9.6 years), frequency of pancolitis (A: 28.6%, N: 56.3%, K: 48.3%) and frequency of solitary lesions (A: 83.7%, N: 23.1%, K: 51.9%). The differential diagnosis between adenoma and colitis-associated neoplasia in patients with ulcerative colitis appears to be possible but the diagnosis should only be made in the remission phase. Furthermore the patients need a careful endoscopic and bioptic follow-up. If in doubt one should consider colitis-associated neoplasia especially when there are multiple intraepithelial neoplastic lesions. Long-term follow-up studies are urgently needed.

Entities:  

Mesh:

Year:  2003        PMID: 12601476     DOI: 10.1007/s00292-002-0601-x

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  27 in total

1.  Distinction between dysplasia-associated lesion or mass (DALM) and adenoma in patients with ulcerative colitis.

Authors:  F Fogt; S J Urbanski; M E Sanders; E E Furth; R L Zimmerman; J J Deren; A E Noffsinger; A O Vortmeyer; C J Hartmann; R L Odze; C A Brown
Journal:  Hum Pathol       Date:  2000-03       Impact factor: 3.466

2.  Cancer surveillance in ulcerative colitis.

Authors:  F W Nugent; R C Haggitt; P A Gilpin
Journal:  Gastroenterology       Date:  1991-05       Impact factor: 22.682

3.  Genetic alterations in chronic ulcerative colitis-associated adenoma-like DALMs are similar to non-colitic sporadic adenomas.

Authors:  R D Odze; C A Brown; C J Hartmann; A E Noffsinger; F Fogt
Journal:  Am J Surg Pathol       Date:  2000-09       Impact factor: 6.394

4.  Prevalence of polyps in an autopsy series from areas with varying incidence of large-bowel cancer.

Authors:  J C Clark; Y Collan; T J Eide; J Estève; S Ewen; N M Gibbs; O M Jensen; E Koskela; R MacLennan; J G Simpson
Journal:  Int J Cancer       Date:  1985-08-15       Impact factor: 7.396

5.  Colonoscopic diagnosis of dysplasia and early cancer in longstanding colitis.

Authors:  K Nagasako; B Iizuka; F Ishii; J Miyazaki; T Fujimori
Journal:  J Gastroenterol       Date:  1995-11       Impact factor: 7.527

6.  Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis.

Authors:  W R Connell; J E Lennard-Jones; C B Williams; I C Talbot; A B Price; K H Wilkinson
Journal:  Gastroenterology       Date:  1994-10       Impact factor: 22.682

7.  Clinical and pathomorphological findings in patients with colorectal carcinoma complicating ulcerative colitis.

Authors:  A Schneider; M Stolte
Journal:  Z Gastroenterol       Date:  1993-03       Impact factor: 2.000

8.  Early onset high grade dysplasia in ulcerative colitis.

Authors:  D Clements; V Suarez; H Thompson; J Alexander-Williams; R N Allan
Journal:  Postgrad Med J       Date:  1988-01       Impact factor: 2.401

9.  Loss of heterozygosity of the von Hippel Lindau gene locus in polypoid dysplasia but not flat dysplasia in ulcerative colitis or sporadic adenomas.

Authors:  F Fogt; A O Vortmeyer; M Stolte; E Mueller; J Mueller; A Noffsinger; C Poremba; Z Zhuang
Journal:  Hum Pathol       Date:  1998-09       Impact factor: 3.466

Review 10.  [Risk of colorectal cancer in ulcerative colitis--monitoring strategies and identification of risk patients].

Authors:  R Porschen; G Strohmeyer
Journal:  Z Gastroenterol       Date:  1992-09       Impact factor: 2.000

View more
  4 in total

Review 1.  Cancer risk in IBD: how to diagnose and how to manage DALM and ALM.

Authors:  Helmut Neumann; Michael Vieth; Cord Langner; Markus F Neurath; Jonas Mudter
Journal:  World J Gastroenterol       Date:  2011-07-21       Impact factor: 5.742

Review 2.  [Pathogenesis of colitis-associated neoplasms].

Authors:  M Vieth; H Neumann
Journal:  Pathologe       Date:  2012-11       Impact factor: 1.011

3.  Sporadic adenoma in ulcerative colitis: endoscopic resection is an adequate treatment.

Authors:  M Vieth; H Behrens; M Stolte
Journal:  Gut       Date:  2006-01-19       Impact factor: 23.059

4.  [Intraepithelial neoplasia/dysplasia - histopathology in ulcerative colitis].

Authors:  G B Baretton; D E Aust
Journal:  Pathologe       Date:  2008-11       Impact factor: 1.011

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.